Effectiveness of intranasal esketamine in the treatment of patients with treatment-resistant depression: an observational study based on data collected in a Spravato treatment program at the Institute of Living, Hartford, CT

Psychopharmacology 2026

View at publisher
Authors: Benjamin Anderson, Andrew Winokur, Grace Chan
DOI: 10.1007/s00213-026-07016-9
Cited by: 1
References: 24

Fields of Study & Subjects

Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior Psychedelics and Drug Studies

Publication details

Journal / source
Psychopharmacology
Publisher
Springer Science and Business Media LLC
Publication date
2 February 2026
Language
EN